Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Bruera

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|September 1, 1996
Comment: opioid-induced muscle activityJ L Pereira, E D Bruera
Medicina|January 1, 1983
[Emesis due to cytostatic drugs. Update and review of our experiences]R D Chacón, E D Bruera, E Roca
Journal of Palliative Care|September 1, 1985
Continuous subcutaneous infusion of narcotics using a portable disposable pumpE D Bruera, S Chadwick, R Bacovsky, et al.
JAMA|November 14, 2000
Delirium at the end of life: critical issues in clinical practice and researchP G Lawlor, R L Fainsinger, E D Bruera
Journal of Palliative Medicine|April 30, 2005
Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective studyI L Mancini, J Hanson, C M Neumann, et al.
Cancer Treatment Reports|April 1, 1983
Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramideE D Bruera, E Roca, L Cedaro, et al.
Cancer|March 20, 1998
Dose ratio between morphine and methadone in patients with cancer pain: a retrospective studyP G Lawlor, K S Turner, J Hanson, et al.
Clinical Breast Cancer|March 20, 2002
Internet usage among women with breast cancer: an exploratory studyJ L Pereira, S Koski, J Hanson, et al.
Journal of Pain and Symptom Management|September 29, 2001
The impact of delirium on the circadian distribution of breakthrough analgesia in advanced cancer patientsB Gagnon, P G Lawlor, I L Mancini, et al.
Cancer|June 28, 2000
Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: Assessing delirium in advanced cancerP G Lawlor, C Nekolaichuk, B Gagnon, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|September 1, 1996
Comment: opioid-induced muscle activityJ L Pereira, E D Bruera
Medicina|January 1, 1983
[Emesis due to cytostatic drugs. Update and review of our experiences]R D Chacón, E D Bruera, E Roca
Journal of Palliative Care|September 1, 1985
Continuous subcutaneous infusion of narcotics using a portable disposable pumpE D Bruera, S Chadwick, R Bacovsky, et al.
JAMA|November 14, 2000
Delirium at the end of life: critical issues in clinical practice and researchP G Lawlor, R L Fainsinger, E D Bruera
Journal of Palliative Medicine|April 30, 2005
Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective studyI L Mancini, J Hanson, C M Neumann, et al.
Cancer Treatment Reports|April 1, 1983
Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramideE D Bruera, E Roca, L Cedaro, et al.
Cancer|March 20, 1998
Dose ratio between morphine and methadone in patients with cancer pain: a retrospective studyP G Lawlor, K S Turner, J Hanson, et al.
Clinical Breast Cancer|March 20, 2002
Internet usage among women with breast cancer: an exploratory studyJ L Pereira, S Koski, J Hanson, et al.
Journal of Pain and Symptom Management|September 29, 2001
The impact of delirium on the circadian distribution of breakthrough analgesia in advanced cancer patientsB Gagnon, P G Lawlor, I L Mancini, et al.
Cancer|June 28, 2000
Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: Assessing delirium in advanced cancerP G Lawlor, C Nekolaichuk, B Gagnon, et al.
Pageof 2